Pfizer to Acquire Meningitis Vaccines From GSK

24.06.2015 - Pfizer has agreed to acquire the quadrivalent meningitis ACWY vaccines Nimenrix and Mencevax from GlaxoSmithKline (GSK) for €115 million. The deal, expected to close in the second...